These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25872662)

  • 1. Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease.
    Ramachandran R; Kumar D A P; Nada R; Jha V; Gupta KL; Kohli HS
    Nephrology (Carlton); 2015 May; 20(5):384-5. PubMed ID: 25872662
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Tang S; Tang AW; Tam MK; Ho YW
    Am J Kidney Dis; 2003 Nov; 42(5):E13-5. PubMed ID: 14582073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome.
    Schweda F; Liebl R; Riegger GA; Krämer BK
    Nephrol Dial Transplant; 1997 Nov; 12(11):2433-5. PubMed ID: 9394341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Minimal Change Glomerulonephritis].
    Stracke S; Helmchen U; Aymanns C; Kadlec N; Lindemann B; Hüttner S; Keller F
    Internist (Berl); 2003 Sep; 44(9):1090-7. PubMed ID: 14566462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of immunodepressive treatment in the nephrotic syndrome.
    Pachiolo R; Genova R
    Helv Paediatr Acta; 1970 Jan; 25(1):50-8. PubMed ID: 5438807
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advances in the treatment of adult nephrotic syndrome].
    Yokoyama H; Asaka M; Yamaya H; Wada T
    Nihon Jinzo Gakkai Shi; 2007; 49(2):108-12. PubMed ID: 17375618
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
    Branten AJ; Wetzels JF
    Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2832-8. PubMed ID: 10065257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal change disease and Kimura's disease responding to tacrolimus therapy.
    Balwani MR; Bawankule CP; Pasari A; Tolani P; Vakil S; Yadav R
    Saudi J Kidney Dis Transpl; 2019; 30(1):254-257. PubMed ID: 30804291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal disease. II. The treatment of minimal change nephropathy and focal segmental glomerulosclerosis.
    Mason PD
    J R Coll Physicians Lond; 1997; 31(2):137-41. PubMed ID: 9131509
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrohematuria with electron-dense deposits in a 14-year-old boy with minimal change nephrotic syndrome.
    Filler G; Robb I; Carpenter B
    Pediatr Nephrol; 2001 Jan; 16(1):91-3; discussion 94-6. PubMed ID: 11198614
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversible acute renal failure in idiopathic nephrotic syndrome with minimal change nephropathy.
    Dash SC; Malhotra KK; Sharma RK; Bhuyan UN
    J Assoc Physicians India; 1982 Jun; 30(6):399-401. PubMed ID: 7169462
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of Adult Minimal Change Disease.
    Korbet SM; Whittier WL
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):911-913. PubMed ID: 30952629
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
    Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
    Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Steroids or cytostatics in the juvenile nephrotic syndrome].
    Brodehl J
    Klin Padiatr; 1972 Jul; 184(4):241-9. PubMed ID: 4567556
    [No Abstract]   [Full Text] [Related]  

  • 16. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome revisited.
    Seibert FS; van der Giet M; Zidek W; Westhoff TH
    Clin Nephrol; 2012 Apr; 77(4):345-6. PubMed ID: 22445479
    [No Abstract]   [Full Text] [Related]  

  • 17. [Steroid-Dependent Nephrotic Syndrome Due to Minimal Change Glomerulonephritis Treated with Rituximab].
    Cristiano F; Verratti V; Di Matteo G; Fulle S; Cristiano J; D'Angelo B; Caravelli L; Posari C; Schiazza A; Piano A
    G Ital Nefrol; 2024 Feb; 41(1):. PubMed ID: 38426681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term steroid-immunosuppressive treatment of the childhood nephrotic syndrome.
    Pachioli R; Genova R
    Pediatrics; 1971 Apr; 47(4):731-6. PubMed ID: 4326172
    [No Abstract]   [Full Text] [Related]  

  • 19. Minimal change nephrotic syndrome with stiff-person syndrome: is there a link?
    Ergün I; Akbostanci MC; Canbakan B; Koçer B; Ensari A; Nergizoglu G; Keven K
    Am J Kidney Dis; 2005 Jul; 46(1):e11-4. PubMed ID: 15983949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of the nephrotic syndrome in children].
    Linneweh F
    Minerva Med; 1973 Oct; 64(76):4007-9. PubMed ID: 4764071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.